Vaccine candidate of Biological E is in it phase-1 clinical trials while Gennovabiopharmaceuticals is in the process of getting approvals at various levels. Serum Institute of India (SII) is also conducting phase 2 and 3 clinical trials of the Oxford-Astrazeneca vaccine.from Top India News- News18.com
Read The Rest:news18..
